Literature DB >> 25635182

Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.

Pankaj Kumar1, Masanao Murakami1, Rajeev Kaul1, Abhik Saha1, Qiliang Cai1, Erle S Robertson2.   

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus associated with a large number of lymphoid and epithelial malignancies. As a successful pathogen it has co-evolved with its human host for millions of years. EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, a small subset of viral proteins is expressed. These proteins are essential for maintenance of the EBV genome as well as the deregulation of various signaling pathways that facilitate the proliferation and survival of the infected cells. Epstein-Barr nuclear antigen (EBNA)3C is one of the latent proteins shown to be essential for transformation of primary human B lymphocytes in vitro. EBNA3C primarily functions as a transcriptional regulator by interacting with a number of well known cellular and viral transcriptional factors. We have recently identified several binding partners for EBNA3C including proteins that regulate cell cycle and chromatin remodeling. We are actively engaged in discerning the biological significance of these interactions. This review summarizes our current understanding of how EBNA3C usurps cellular pathways that promote B-cell transformation.

Entities:  

Keywords:  Epstein–Barr nuclear antigen 3C; Epstein–Barr virus; cell cycle; latency; transcriptional regulator; viral transformation

Year:  2009        PMID: 25635182      PMCID: PMC4307939          DOI: 10.2217/17460794.4.1.79

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  99 in total

Review 1.  Cyclins and cell cycle checkpoints.

Authors:  D G Johnson; C L Walker
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 2.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 3.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

4.  EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.

Authors:  Elena Kashuba; Mariya Yurchenko; Surya Pavan Yenamandra; Boris Snopok; Maria Isaguliants; Laszlo Szekely; George Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

5.  Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells.

Authors:  Robert Touitou; Jenny O'Nions; Judith Heaney; Martin J Allday
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

6.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.

Authors:  G A Parker; T Crook; M Bain; E A Sara; P J Farrell; M J Allday
Journal:  Oncogene       Date:  1996-12-19       Impact factor: 9.867

8.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

9.  Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.

Authors:  B Tomkinson; E Kieff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 10.  CtBP family proteins: more than transcriptional corepressors.

Authors:  G Chinnadurai
Journal:  Bioessays       Date:  2003-01       Impact factor: 4.345

View more
  2 in total

1.  Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.

Authors:  Hanno M Witte; Axel Künstner; Nadine Hertel; Heinz-Wolfram Bernd; Veronica Bernard; Stephanie Stölting; Hartmut Merz; Nikolas von Bubnoff; Hauke Busch; Alfred C Feller; Niklas Gebauer
Journal:  Blood Adv       Date:  2022-01-25

Review 2.  Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives.

Authors:  Julio C Osorio; Rancés Blanco; Alejandro H Corvalán; Juan P Muñoz; Gloria M Calaf; Francisco Aguayo
Journal:  Pathogens       Date:  2022-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.